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Abstract: The tolerance model of acute (i.e., wasting) pre-pubescent protein and energy 
deficits proposes that the immune depression characteristic of these pathologies reflects an 
intact anti-inflammatory form of immune competence that reduces the risk of autoimmune 
reactions to catabolically released self antigens. A cornerstone of this proposition is the 
finding that constitutive (first-tier) interleukin(IL)-10 production is sustained even into the 
advanced  stages  of  acute  malnutrition.  The  IL-10  response  to  inflammatory  challenge 
constitutes  a  second  tier  of  anti-inflammatory  regulation  and  was  the  focus  of  this 
investigation. Weanling mice consumed a complete diet ad libitum, a low-protein diet ad 
libitum  (mimicking  incipient  kwashiorkor),  or  the  complete  diet  in  restricted  daily 
quantities (mimicking marasmus), and their second-tier IL-10 production was determined 
both in vitro and in vivo using lipopolysaccharide (LPS) and anti-CD3 as stimulants of 
innate and adaptive defences, respectively. Both early (3 days) and advanced (14 days) 
stages  of  wasting  pathology  were  examined  and  three  main  outcomes  emerged.  First, 
classic in vitro systems are unreliable for discerning cytokine production in vivo. Secondly, 
in diverse forms of acute malnutrition declining challenge-induced IL-10 production may 
provide an early sign that anti-inflammatory control over immune competence is failing. 
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Thirdly, and most fundamentally, the investigation provides new support for the tolerance 
model of malnutrition-associated inflammatory immune depression. 
Keywords: anti-inflammatory; immune tolerance; interleukin-10; mouse; protein-energy 
malnutrition 
 
1. Introduction 
In its most severe forms, acute pre-pubescent malnutrition manifests in two distinct pathologies, 
namely marasmus and kwashiorkor, and susceptibility to opportunistic infections is characteristic of 
both  [1,2].  Depressed  inflammatory  immune  competence  is  widely  accepted  as  the  link  between 
malnutrition and susceptibility to infection [1,2], and proof-of-principle evidence demonstrates that 
inflammatory  capabilities  can  be  increased  independently  of  ongoing  weight  loss  in  acute  
pre-pubescent  deficits  of  protein  and  energy  [3,4].  There  is  reason  for  optimism,  therefore,  that 
improved  understanding  of  malnutrition-associated  immunological  change  will  lead  to  improved 
management of infection even in the most advanced stages of acute protein and energy deficits.  
Malnutrition-associated  immune  depression  is  widely  attributed  to  a  disintegrative  loss  of 
inflammatory capacities [5-7] and the loss is tacitly assumed to include the ability to both generate and 
resolve  an  inflammatory  response.  However  this  longstanding  paradigm  is  under  challenge  by  a 
proposition centered on regulated preservation of anti-inflammatory immune capability [1,5-7]. Briefly, 
the so-called “tolerance model” identifies malnutrition-related immune depression as a physiological 
strategy to reduce the risk of inflammatory autoimmune reactions in the face of catabolically-released 
self antigens [3,7]. The model acknowledges the resulting cost in terms of susceptibility to infection [7] 
and accommodates the biologically trivial endpoint that a disintegrative loss of all forms of immune 
competence must ultimately prevail if wasting disease is permitted to proceed indefinitely.  
The  tolerance  model  centers  on  three  anti-inflammatory  mediators,  namely  the  glucocorticoids, 
transforming growth factor(TGF)- and interleukin(IL)-10. This hormonal triad plays a determining 
role in physiological anti-inflammatory control and in the maintenance of self tolerance [8-13]. The 
constitutive  blood  levels  of  these  mediators  are  positioned,  collectively,  to  respond  when  an 
inflammatory  challenge  is  first  encountered  and,  consequently,  they  represent  the  first  tier  of  
anti-inflammatory  and  regulatory  immune  competence. Recently,  high  constitutive  blood  levels  of 
each  member  of  this  anti-inflammatory  triad  have  been  reported  in  weanling  mouse  models  of 
marasmus  and  incipient  kwashiorkor  [5-7,14],  models  which  consistently  reproduce  the  critical 
features of these pediatric pathologies [5,14-18]. Further, remarkably, the systemic rate of constitutive 
IL-10 production is at least sustained, and can even be elevated, into the advanced stages of wasting 
pathology in the same high-fidelity mouse models of pre-pubescent malnutrition [7], thereby providing 
the first mechanistic evidence supporting the tolerance model. 
In  addition  to  their  constitutive  production,  anti-inflammatory  mediators  are  released  as  a 
component  of  any  competent  response  to  inflammatory  stimuli  [19].  Thus,  stimulus-dependent 
production of soluble mediators may be regarded as a second tier of anti-inflammatory and tolerogenic 
immune  regulation.  The  concept  of  layers  of  anti-inflammatory  regulation  has  been  espoused Int. J. Environ. Res. Public Health 2011, 8                 
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previously and both innate and adaptive types of second-tier responses can be identified [20]. IL-10 is 
a particularly important anti-inflammatory mediator that regulates both innate and adaptive immune 
responses  [21,22].  However,  information  is  unavailable  pertaining  to  the  influence  of  acute  
pre-pubescent protein and energy deficits on second-tier IL-10 production. Therefore, the objective of 
this investigation was to assess the influence of metabolically distinct forms of acute malnutrition on 
innate and adaptive-type second-tier IL-10 production using weanling mouse models known to sustain 
constitutive production of this anti-inflammatory cytokine. Within this objective, the primary purpose 
was to assess stimulant-induced cytokine production in vivo, whereas a secondary purpose was to 
determine whether the more common strategy of assessing the response to stimulation in vitro would 
yield a similar outcome. Lipopolysaccharide (LPS) potently activates innate immune defences through 
the toll-like receptor(TLR)-4 [23] and was selected to elicit an innate-type response. The adaptive-type 
response was investigated by stimulating the effector/memory T cell compartment, an important source 
of IL-10 in the context of acquired immune competence [22], using anti-CD3 as a polyclonal stimulant. 
2. Materials and Methods 
2.1. Animals and Housing Facilities 
Male and female C57BL/6J mice were obtained from an in-house breeding colony derived from 
animals originally purchased from the Jackson Laboratory (Bar Harbor, ME). Caging and housing 
conditions  were  exactly  as  described  previously  [5-7,14-18].  Briefly,  the  animals  were  held  in  a 
windowless room supplied with fluorescent lighting on a 14L:10D schedule, while temperature and 
relative  humidity  were  regulated  at  25–26  ° C  and  60–70%,  respectively.  This  investigation  was 
approved by the Animal Care Committee of the University of Guelph in accordance with the Canadian 
Council on Animal Care. 
2.2. Diets 
Eighteen-day-old  animals  were  weaned  and  acclimated  overnight  to  a  complete  purified  diet 
described in detail elsewhere [24]. The diet was made using spray-dried egg white as its source of 
nitrogen  together  with  cornstarch,  glucose,  corn  oil,  cellulose  and  a  micronutrient  supplement 
formulated according to the classic AIN-76 diet for rodents. A typical proximate analysis of the diet 
(as-fed basis) is 93% dry matter, 18% crude protein, 8% ether extract, 2.6% ash, 3% crude fibre and  
17 kJ/g gross energy. Following the acclimation period, equal numbers of male and female 19-day-old 
mice were randomly assigned to one of three experimental groups, namely an age-matched control 
group  consuming  the  complete  purified  diet  ad  libitum,  a  restricted-intake  group  consuming  the 
complete purified diet in restricted daily quantities based on calculations that relate ad libitum food 
intake (g food/g body weight) to chronological age in the weanling mouse [15], or a low-protein group 
consuming  ad  libitum  a  nitrogen-deficient  purified  diet  that  was  isocaloric  with  the  complete 
formulation  [5,16].  To  make  the  low-protein  diet,  the  complete  diet  was  re-designed  by  
weight-for-weight replacement of a portion of the cornstarch to achieve a crude protein level of 0.6%. 
The restricted-intake protocol produces a pathology that reproduces the critical features of pediatric 
marasmus, whereas the low-protein model closely resembles incipient pediatric kwashiorkor [5,14-18]. Int. J. Environ. Res. Public Health 2011, 8                 
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2.3. Experimental Design 
Innate and adaptive capacities to produce IL-10 in response to appropriate stimulation were each 
assessed  by  means  of  two  experiments,  one  conducted  in  vivo  and  the  other  in  vitro.  In  all  four 
experiments, cohorts of animals were maintained on each of the three dietary regimens for 14 days,  
i.e., from 19 through 33 days of age. Additionally, in the two experiments centered on the in vivo 
response,  a  cohort  of  animals  from  each  dietary  protocol  was  examined  after  only  3  days  
(i.e., at 22 days of age), a time point taken to represent early-stage weight loss in the malnourished 
groups [6,7,14]. Carcasses from animals of all experiments were stored at −20 ° C to await analysis. It 
should be noted that female estrous cycling (at least on the part of age-matched control animals) may 
have contributed variance to the design of the studies involving a 14-day feeding period. Part of the 
intent, however, was to determine whether malnutrition-related influences could be discerned against a 
background of normal physiological variability.  
IL-10 production in vivo in response to stimulation by either LPS or anti-CD3 was assessed at day 3 
(early time  point) and day 14 (advanced weight loss), thus yielding a 2  ×  2 design in which the 
statistical main effects were diet and stage of weight loss. Eight mice (four males and four females) 
were included within each dietary group at each time point. Unstimulated negative controls, effectively 
providing a measure of constitutive IL-10 production, were included within each dietary group and 
stage of weight loss in both experiments (n = 16, eight males and eight females per group, in the 
investigation of the innate response to LPS and n = 3, two males and one female per group, in the 
study of the adaptive T cell response).  
A sample size of six per dietary group was used to investigate the innate response to LPS in vitro, 
whereas the in vitro response of effector/memory T cells (to stimulation by anti-CD3) was investigated 
using  a  sample  of  ten  mice  in  the  age-matched  control  group  and  eight  animals  in  each  of  the 
malnourished groups. Equal numbers of males and females were included in all experimental groups. 
In order to obtain sufficient numbers of cells from secondary lymphoid organs (spleen combined with 
mesenteric  and  inguinal  lymph  nodes),  pooled  samples  were  required  for  mice  subjected  to  the  
low-protein  and  restricted-intake  groups.  Thus,  in  the  study  of  the  in  vitro  response  to  LPS  each 
sample from the low-protein and restricted-intake groups comprised two and four mice, respectively, 
whereas 2–4 low-protein mice and 2–8 restricted-intake mice were pooled to produce each sample of 
malnourished animals in the study of the in vitro response of effector/memory T cells. Each pooled 
sample included equal numbers of males and females and constituted a single degree of freedom for 
the purpose of statistical analysis. The experiments centered on in vitro responses were conducted 
according to a 2 ×  2 design with diet and in vitro stimulation as the statistical main effects, and cells 
were harvested for study at the end of the 14-day experimental period. 
2.4. In vivo Stimulation of IL-10 and Assessment of Cytokine Production by in vivo Capture Assay 
An in vivo cytokine capture assay kit for murine IL-10 (BD Biosciences, Mississauga, Canada, 
catalogue # 558072) was utilized as described previously [7]. Briefly, each animal received an aseptic 
intraperitoneal injection of 10 µ g of biotin-conjugated anti-mouse IL-10 (“capture”) antibody delivered 
in 200 µ L of endotoxin-free physiological saline (Vé toquinol N.–A. Inc., Lavaltrie, Qué bec, Canada; Int. J. Environ. Res. Public Health 2011, 8                 
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henceforth, “saline”). Animals used for assessment of the innate response to endotoxin received a 
simultaneous  intraperitoneal  injection  of  LPS  (Escherichia  coli  055:B5,  Sigma-Aldrich,  St.  Louis, 
USA), 1 μg/g body weight, whereas mice used in the investigation of T cell-derived IL-10 were given 
a simultaneous intraperitoneal injection of 10 µ g of anti-mouse CD3 (clone: 145-2C11, Armenian 
hamster IgG; BD Bioscience, San Diego, CA, USA). Negative controls for the mice given LPS each 
received  10  μg  of  the  capture  antibody,  only,  but  negative  controls  for  the  mice  stimulated  with  
anti-CD3  received  10  µ g  of  capture  antibody  plus  10  µ g  of  Armenian  hamster  IgG  (catalog  #  
G235-2356, BD Biosciences, San Diego, CA, USA) by intraperitoneal injection in 200 µ L of sterile 
saline. Blood samples were collected 4 hours later to permit analysis of the concentration of IL-10 that 
had  accumulated  in  molecular  complexes  with  the  capture  antibody.  LPS  and  anti-CD3  have 
previously been utilized successfully in combination with the capture assay [25,26]. Moreover, four 
hours provides ample time to generate elevated serum IL-10 concentrations in response to stimulation 
either by LPS [25,26] or by anti-CD3 [26]. 
A sandwich ELISA was used to detect the antibody/cytokine complexes and was performed with 
reagents provided in the capture assay kit (BD Biosciences). The capture reagent of the ELISA was a 
rat monoclonal antibody that recognized a different IL-10 epitope than the biotin-conjugated capture 
antibody  used  in  vivo,  and  the  detection  reagent  was  streptavidin  conjugated  with  horse  radish 
peroxidase. In a minor departure from the manufacturer’s instructions, an additional blocking step was 
included using 10% fetal bovine serum (Sigma Chemical) in sterile PBS (1.0 mM, pH 7.3) following 
the capture stage of the ELISA. Outcomes were quantified by optical density using a Vmax kinetic 
plate  reader  (Molecular  Devices  Corp.,  Menlo  Park,  CA)  set  for  absorbance  at  450  nm  with 
wavelength correction based on absorbance at 570 nm.  
The reliability (intra-assay coefficient of variation) and detection limit of each assay were estimated 
as described previously [27] and averaged 4.3% and 0.14 pg/mL (of IL-10 in molecular complex) 
respectively. The standard curves for the assay were linear (mean R
2 = 0.99) over a concentration 
range up to 2,000 pg/mL. All samples fell within the linear portion of the curve and exceeded the 
detection limit of the assay.  
2.5. Blood Sampling Procedure for the in vivo Capture Assay 
As described previously [14] blood samples were collected from the orbital plexus while the mice 
were under CO2 anesthesia, and the mice were then killed by cervical dislocation without recovering 
consciousness. Blood was allowed to clot at room temperature for 30–45 minutes and the resulting 
serum was stored at −80 ° C to await analysis. 
2.6. Procedure to Obtain Mononuclear Cell Suspensions for in vitro Stimulation 
After  measurement  of  body  weight,  mice  were  anesthetized  with  CO2  and  killed  by  cervical 
dislocation without recovering consciousness. The spleen and the mesenteric and inguinal lymph nodes 
were  removed  aseptically,  diced  together  and  forced  through  a  sterile  stainless  steel  wire  screen  
(100-mesh)  into  RPMI  1640  medium  (Flow  Laboratories,  Mississauga,  Canada)  containing  10%  
heat-inactivated  fetal  bovine  serum  (Sigma  Chemical,  St.  Louis,  MO),  1  mmol/L  HEPES  (ICN 
Biomedicals,  Aurora,  OH),  10
5  U/L  penicillin  and  100  mg/L  streptomycin  (hereafter  designated Int. J. Environ. Res. Public Health 2011, 8                 
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“complete medium”). A single-cell suspension of mononuclear cells was produced by discontinuous 
gradient  centrifugation  as  described  previously  [28].  Cell  numbers  were  determined  using  a 
hemocytometer and viability, assessed by eosin Y exclusion, always exceeded 95%.  
2.7. In vitro Stimulation of Mononuclear Cells with LPS to Elicit IL-10 Production 
Each  well  of  a  96-well  V-bottom  plate  (catalog  #249662,  Nalge  Nunc  International),  received  
2 ×  10
5 viable mononuclear cells in 190 μL complete medium. Subsequently, 10 μL of complete 
medium was added to half of the culture wells to generate unstimulated negative control cultures while 
the remaining wells received 10 μL of LPS (Escherichia coli 055:B5, Sigma–Aldrich, St. Louis, USA) 
diluted in complete medium to achieve a final concentration of 10 μg/mL in each well. All cultures 
were run in triplicate and incubated at 37 °C  for 24 h. After incubation, supernatants from each set of 
triplicate wells were produced by centrifugation at 200 g and the supernatants were pooled, subdivided 
into aliquots and stored at −80 °C .  
2.8. In vitro Stimulation of T Cells with Anti-CD3 to Elicit IL-10 Production 
Falcon plates (flat-bottom wells, Becton Dickinson Labware, New Jersey, USA, catalog #3072) 
were coated overnight at 4 °C  with 200 μL 0.01 M phosphate-buffered saline (PBS, pH 7.3) containing 
5 μg/mL anti-CD3 (clone: 145-2C11; Cedarlane Laboratories, Hornby, Canada). After coating, plates 
were washed twice with PBS and each well received 2 ×  10
5 viable mononuclear cells in 190 μL 
complete medium. Subsequently, 10 μL of PBS was added to  half of the culture wells while the 
remaining  test  cultures  received  10  μL  of  PBS  containing  anti-CD28  (clone:  37.51.1;  Cedarlane 
Laboratories, Hornby, Canada) to achieve a final concentration of 20 μg/mL. Negative control cultures 
were produced using wells not coated with anti-CD3 and the cells were cultured in fluids comprising 
190 µ L complete medium together with 10 µ L PBS. All cultures were incubated at 37 °C  for 24 h. 
After  incubation,  plates  were  centrifuged  for  1  min  at  200  g,  and  supernatants  from  cultures 
representing the same dietary group and stimulus were pooled and stored at −80 °C . 
2.9. Assay of IL-10 Concentrations Generated in vitro 
A sandwich ELISA kit for assay of mouse IL-10 (BD Biosciences, Mississauga, ON, catalogue 
#555252) was applied to samples of culture fluids as described by the manufacturer. Outcomes based 
on triplicate assays were quantified by optical density using a Vmax kinetic plate reader (Molecular 
Devices Corp., Menlo Park, CA) set for absorbance at 450 nm with wavelength correction based on 
absorbance at 570 nm. Only the linear portions of standard curves were used (mean R
2 = 0.97, at 
minimum), and all samples fell within this part of the curve. In the studies of innate and adaptive 
responses, the reliability of the assay (intra-assay coefficient of variation) averaged 5.8% and 8.1%, 
respectively,  and  its  detection  limit,  determined  as  described  elsewhere  [27],  averaged  2.2  and  
1.2 pg/mL, respectively. Int. J. Environ. Res. Public Health 2011, 8                 
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2.10. Assessment of Percentage CD3
+ Cells in Mononuclear Cell Suspensions from Spleen and  
Lymph Nodes 
Analyses were performed using a Becton-Dickinson FACSCalibur flow cytometer equipped with 
BD CellQuest TM software (2001). Generic aspects of staining procedures in this laboratory, including 
Fc receptor blockade, are described elsewhere [15,28]. Cells were subjected to single-color analysis by 
means  of  a  phycoerythrin-conjugated  anti-mouse  CD3ε  monoclonal  antibody  (clone:  145-2C11, 
Armenian hamster IgG, eBiosciences, San Diego, CA, USA) at a concentration of 0.2 µ g per 250 ×  10
3 
viable cells. Negative control samples were stained with biotin-conjugated hamster IgG (Cedarlane 
Laboratories,  Hornby,  ON)  followed  by  phycoerythrin-conjugated  streptavidin  (Cedarlane 
Laboratories, Hornby, ON), respectively at concentrations of 0.2 µ g and 0.15 µ g per 250 ×  10
3 viable 
cells. Cells were incubated with staining reagents in the dark on ice for 40 min and then were fixed 
with paraformaldehyde (20 g/L) and analyzed immediately. Viability before staining was determined 
by eosin Y exclusion and always exceeded 95%. Each analysis was based on at least 10
4 events after 
dead  cells  and  residual  erythrocytes  were  eliminated  by  gating  on  the  basis  of  forward-angle  
light scatter. 
2.11. Assessment of Carcass Composition 
Carcasses from animals of both experiments were stored at −20 °C  to await analysis. Analyses of 
dry matter and total lipid content were performed as described previously [14,15]. 
2.12. Statistical Analyses 
Statistical analyses were conducted using the SAS system (SAS Institute, Cary, NC, USA) for 
Windows (version 9.0), and a predetermined upper limit of probability of P ≤ 0.05 was applied for 
statistical significance. Data were subjected to a two-way ANOVA followed, if justified by the level of 
statistical probability (P ≤ 0.05), by Tukey’s Studentized Range test. If a data set failed to exhibit 
normal distribution according to each of the four tests applied by the SAS program (P ≤ 0.05) then a 
transformation was utilized to bring it into conformity with this basic assumption of parametric testing. 
3. Results 
3.1. Distinct Weight Loss Pathologies Were Elicited by the Malnutrition Protocols 
Growth  indices  for  the  experiments  pertaining  to  the  primary  interest  of  this  investigation,  
i.e., IL-10 production in vivo, are shown in Table 1 (innate response to LPS) and Table 2 (T cell 
response to anti-CD3), and the results were comparable in the two experiments. Initial body weights 
did not differ among the dietary groups and body weight gain, food intake and carcass composition of 
the age-matched control group were comparable to previous results pertaining to C57BL/6J weanlings 
given free access to the complete diet used in this investigation at both time points [5,7,14,16,17,24]. 
The final body weights of the malnourished groups were lower than those of their corresponding  
age-matched control groups but did not differ from each other. In addition, the malnourished groups 
exhibited  decreased  food  intakes  relative  to  their  corresponding  age-matched  controls,  as  seen Int. J. Environ. Res. Public Health 2011, 8                 
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previously [7,14-16]. Moreover, the malnourished groups exhibited a lower percentage of carcass fat 
than controls, but the extent of carcass fat loss was more pronounced in the restricted-intake group at 
both  stages  of  weight  loss  that  were  assessed.  Therefore,  as  reported  elsewhere  [5,17,29],  the 
restricted-intake protocol induced a greater decrement in carcass energy than the low-protein protocol, 
and this was apparent even at an early stage of weight loss. Importantly, the wasting disease produced 
by  the  two  malnutrition  protocols  was  comparable  to  that  reported  in  previous  studies  wherein 
inflammatory  immune  competence  was  shown  to  be  depressed  [15,30,31].  Similar  outcomes  with 
respect  to  growth  indices  were  apparent  in  the  experiments  centered  on  the  in  vitro  response  to 
stimulation with LPS and anti-CD3 (results not shown). 
Table 1. Response to LPS stimulation in vivo: Performance outcomes of weanling mice 
after 3-day or 14-day experimental protocols initiated at 19 days of age
 1. 
  Dietary Group
 2   
Index  C  LP  R  SEM 
Day 3 
Initial body weight (g/mouse)  8.5  8.4  8.6  0.10 
Final body weight (g/mouse)  10.4
 X  7.2
 Y  7.4
 Y  0.10 
Food intake (g/mouse ·  3d)
 3  7.8
 X  4.5
 Y  3.6
 Y  0.20 
Food intake (g/g body weight ·  d)
3  0.19
 X  0.13
 Y  0.09
 Z  0.001 
Carcass dry matter (g/100g wet weight)  30.3
 X  28.3
 Y  27.9
 Y  0.30 
Carcass lipid (g/100g wet weight)
4  9.2
 X  5.9
 Y  3.4
 Z  0.03 
Day 14 
Initial body weight (g/mouse)  8.3  8.5  8.6  0.08 
Final body weight (g/mouse)
 4  17.5
 X  6.1
 Y  6.0
 Y  0.02 
Food intake (g/mouse ·  14d)
 5  60.6
 X  18.2
 Y  12.6
 Z  0.01 
Food intake (g/g body weight ·  d)  0.20
 X  0.11
 Y  0.08
 Z  0.002 
Carcass dry matter (g/100g wet weight)  32.1
 X  28.1
 Y  26.5
 Z  0.26 
Carcass lipid (g/100g wet weight)  10.4
 X  4.5
 Y  2.7
 Z  0.34 
1 Mean values. Within a row, values not sharing a superscript letter differ (P ≤ 0.05) according to 
Tukey’s Studentized Range test. 
2 C: group that consumed complete diet ad libitum; LP: group that consumed low-protein diet ad 
libitum; R: group that consumed complete diet in restricted daily quantities. 
3 From ANOVA of squared-transformed data. Mean values are square roots of squared means. 
4 From ANOVA of natural log-transformed data. Mean values are antilogs of log means. 
5 From ANOVA of inverse-transformed data. Mean values are the inverse of the transformed means. Int. J. Environ. Res. Public Health 2011, 8                 
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Table 2. Response to anti-CD3 stimulation in vivo: Performance outcomes of weanling 
mice after 3-day and 14-day experimental protocols initiated at 19 days of age
 1. 
  Dietary Group
 2   
Index  C  LP  R  SEM 
Day 3 
Initial body weight (g/mouse)  8.4  8.5  8.7  0.09 
Final body weight (g/mouse)  10.1
 X  7.4
 Y  7.5
 Y  0.12 
Food intake (g/mouse ·  3 d)
 3  7.5
 X  4.9
 Y  3.5
 Z  0.04 
Food intake (g/g body weight ·  d)
 4  0.18
 X  0.13
 Y  0.09
 Z  0.24 
Carcass dry matter (g/100g wet weight)
3  30.4
 X  29.6
 X  27.4
 Y  0.01 
Carcass lipid (g/100g wet weight)  8.0
 X  6.1
 Y  3.8
 Z  0.23 
Day 14 
Initial body weight (g/mouse)  8.8  8.6  8.8  0.10 
Final body weight (g/mouse)
 3  18.5
 X  6.5
 Y  6.2
 Y  0.02 
Food intake (g/mouse ·  14 d)
 3  65.6
 X  16.6
 Y  11.2
 Z  0.03 
Food intake (g/g body weight ·  d)
 3  0.27
 X  0.10
 Y  0.07
 Z  0.02 
Carcass dry matter (g/100g wet weight)
 3  32.8
 X  27.9
 Y  26.8
 Y  0.02 
Carcass lipid (g/100g wet weight)
 3  10.0
 X  4.1
 Y  2.0
 Z  0.04 
1 Mean values. Within a row, values not sharing a superscript letter differ (P ≤ 0.05) according to 
Tukey’s Studentized Range test. 
2 C: group that consumed complete diet ad libitum; LP: group that consumed low-protein diet ad 
libitum; R: group that consumed complete diet in restricted daily quantities. 
3 From ANOVA of natural log-transformed data. Mean values are antilogs of log means. 
4 From ANOVA of inverse-transformed data. Mean values are the inverse of the transformed means. 
3.2. IL-10 Production in vivo and in vitro in Response to Either LPS or Anti-CD3 
3.2.1. IL-10 capture in vivo following stimulation with LPS 
Analysis  of  the  data  from  the  age-matched  control  groups  (days  3  and  14)  verified  the  LPS 
stimulation protocol  for the purpose of this  investigation. A two-way ANOVA revealed an IL-10 
response to LPS (P = 0.002) that was dependent on chronological age (P = 0.003 for interaction 
between  stimulus  and  age),  and  subsequent  Least  Squares  Means  comparisons  revealed  an  
LPS-induced increase in the blood concentration of captured IL-10 at 33 days of age (i.e., day 14; 
means: 218 vs. 916 pg/mL, P = 0.0001) but no response to LPS at 22 days of age (i.e., day 3; means: 
408  vs.  422  pg/mL,  P  =  0.914).  Thus,  the  LPS  stimulus  elicited  IL-10  production  in  healthy  
pre-pubescent mice permitted to develop this response capability as a part of their normal ontogeny. 
Within the unstimulated control animals of the full data set (all diet groups and both ages), there 
was  no  effect  of  diet  (P  =  0.46)  or  stage  of  weight  loss  (P  =  0.92)  on  the  concentration  of  
antibody-captured serum IL-10. Consequently, the data were pooled to yield a correction factor of  
253 pg/mL, effectively an estimate of constitutive IL-10 production in vivo, which was applied, by Int. J. Environ. Res. Public Health 2011, 8                 
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subtraction, to each LPS-stimulated animal. Figure 1A, therefore, pertains to LPS-stimulated IL-10 
production, only.  
As shown in Figure 1A, a two-way ANOVA (pooled SEM = 0.80) revealed main effects of diet  
(P = 0.0001) and stage of weight loss (P = 0.012) together with a statistically significant interaction 
term (diet X stage, P = 0.025). Bars represent mean values (squared means of square root transformed 
data)  and  an  SEM  is  shown  for  each  mean.  According  to  Least  Squares  Means  analysis  a  lower 
response  to  LPS  was  apparent  in  both  malnourished  groups  (LP:  low-protein  group;  R:  
restricted-intake  group)  relative  to  age-matched  controls  (group  C)  when  weight  loss  was  in  its 
advanced stages, i.e., at day 14 (P ≤ 0.05, bars marked with an asterisk). In fact, an LPS response was 
undetectable  in  the  restricted-intake  group  at  this  stage.  By  contrast,  no  difference  was  apparent 
between either of the malnourished groups and the age-matched control group at the early stage of 
weight loss (day 3). Moreover, comparison between the age-matched control groups (day 3 vs. day 14) 
confirmed the ontogeny-associated rise in IL-10 production in response to LPS stimulation (P = 0.0009, 
Least Squares Means). Thus, the normal ontogenetic rise in LPS-stimulated IL-10 production was 
attenuated as malnutrition progressed in both forms of wasting pathology. 
Figure 1. Serum concentration of IL-10 induced by LPS challenge (panel A) and anti-CD3 
challenge (panel B) in vivo and complexed with biotin-conjugated anti-IL10 antibody.  
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3.2.2. IL-10 capture in vivo following stimulation with anti-CD3 
Analysis of the data from the age-matched control groups (days 3 and 14) verified the anti-CD3 
stimulation protocol  for the purpose of this  investigation. A two-way ANOVA revealed an IL-10 
response to anti-CD3 (P = 0.030) but no effect of chronological age (P = 0.340) and no interaction 
between the statistical main effects (P = 0.969). Thus, the anti-CD3 stimulus elicited an increase in the 
blood concentration of captured IL-10 (means: 221 vs. 820 pg/mL) in healthy pre-pubescent mice at 
both stages of ontogeny examined herein. 
No effect of diet (P = 0.28) or stage of weight loss (P = 0.38) was apparent among the isotype 
control groups, and their average serum level of antibody-captured IL-10 was 297 pg/mL. Therefore 
this  correction  factor,  corresponding  to  constitutive  IL-10  production  in  vivo,  was  applied  
(by subtraction) to each anti-CD3-stimulated animal to ascertain the magnitude of the systemic IL-10 
response to polyclonal T cell stimulation, and the outcome is shown in Figure 1B.  
As shown in Figure 1B, a two-way ANOVA (pooled SEM = 1.60) revealed a diet-related effect  
(P = 0.016) but no effect of the stage of weight loss (P = 0.70) and no interaction term (diet X stage,  
P = 0.26). Consequently, the data were combined across stages of weight loss to produce the results 
shown in the Figure. Bars represent mean values (squared means of square root transformed data) and 
an  SEM  is  shown  for  each  mean.  Bars  not  sharing  a  symbol  differ  from  each  other  (P  ≤  0.05) 
according to Tukey’s Studentized Range test. As revealed by the Figure, the 4-hour accumulation of 
captured IL-10 in the blood of the restricted-intake group (group R) was depressed, independently of 
the stage of weight loss, relative to age-matched controls (group C). Conversely, the response of the 
low-protein  (LP)  group  to  polyclonal  T  cell  stimulation  did  not  differ  from  that  of  either  the  
age-matched controls or the restricted intake group. 
3.2.3. IL-10 production by mononuclear cells stimulated in vitro with LPS 
Data pertaining to the in vitro production of IL-10 in response to LPS were subjected to a two-way 
ANOVA (main effects being diet and stimulus, the latter discerned by comparing cultures with and 
without LPS). The outcome revealed an effect of stimulus (P < 0.0001) but no effect of diet (P = 0.92) 
and no interaction term (P = 0.84). The magnitude of the 24-hour response to LPS was then assessed 
by subtraction of the IL-10 concentrations found in the negative control cultures. The outcome of this 
calculation is shown in Figure 2A and provided, for each dietary group, a measure of LPS-stimulated 
IL-10 production above constitutive levels.  
Figure 2A presents the outcome of a one-way ANOVA which revealed no diet-related effect on the 
production of IL-10 by splenic and nodal mononuclear cells in response to LPS in vitro (P = 0.47; 
pooled  SEM  =  36.1).  Each  bar  represents  a  mean  value  (C:  age-matched  control  group;  LP:  
low-protein group; R: restricted-intake group) and is accompanied by its corresponding SEM. Int. J. Environ. Res. Public Health 2011, 8                 
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Figure 2. Concentration of IL-10 in cultures of mononuclear cells from spleen and lymph 
nodes in response to 24 hours of stimulation in vitro with either LPS (panel A) or anti-CD3 
(panel B). 
 
3.2.4. IL-10 production by mononuclear cells stimulated in vitro with anti-CD3 
The concentration of IL-10 in culture fluids was expressed per 10
5 CD3
+ mononuclear cells, and 
analysis of these data by two-way ANOVA revealed an effect of stimulus (P = 0.0081) but no effect of 
diet (P = 0.16) and no interaction term (P = 0.70). With respect to the effect of stimulus, plate-bound 
anti-CD3 increased IL-10 production (when compared to PBS) but addition of anti-CD28 to provide a 
second stimulus made no difference to IL-10 concentrations relative to stimulation with anti-CD3, 
alone (Tukey’s Studentized Range test, P > 0.05). Therefore, the magnitude of the 24-hour response to 
anti-CD3 stimulation was determined by combining the outcomes of stimulated cultures independently 
of the involvement of the CD28 receptor followed by subtraction of the IL-10 concentrations found in 
corresponding negative control (PBS) cultures. The outcome of this calculation is shown in Figure 2B 
and provided, for each dietary group, a measure of anti-CD3-stimulated IL-10 production by T cells 
above constitutive levels.  
As shown in Figure 2B, a one-way ANOVA revealed no diet-related difference in the production of 
IL-10 in response to anti-CD3 in vitro when expressed on a per 10
5 splenic and nodal CD3
+ cell basis Int. J. Environ. Res. Public Health 2011, 8                 
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(P = 0.32; pooled SEM = 0.18). In the Figure, bars represent mean values (anti-logs of means from 
natural  log-transformed  data)  for  each  dietary  group  (C:  age-matched  control;  LP:  low-protein;  
R: restricted-intake). The data were pooled across stimuli (CD3 ±  CD28) because the second stimulus, 
through the CD28 receptor, elicited no additional IL-10 production beyond the response generated 
through the CD3 receptor. An SEM is shown for each mean value. 
The foregoing analysis and calculation required an assessment of the percentage of CD3
+ (T) cells 
within  the  mononuclear  populations  recovered  from  the  spleen  and  lymph  nodes.  As  reported 
previously in the same experimental systems [17,18], the percentage of CD3
+ mononuclear cells was 
higher  in  the  low-protein  group  than  in  the  age-matched  controls  (means:  44.7%  and  29.9%, 
respectively), whereas the restricted-intake group (mean: 39.0%) did not differ from either of the other 
two dietary groups in this respect (Tukey’s Studentized Range test, pooled SEM = 3.36). 
4. Discussion 
The  present  investigation  centered  on  challenge-induced  production  of  IL-10,  a  component  of 
second-tier anti-inflammatory immune regulation, in relevant and metabolically distinct forms of acute 
malnutrition in the weanling mouse. The challenge imposed in these investigations dictated the nature 
of the responses generated i.e., an innate or adaptive immune response elicited by way of LPS or  
anti-CD3, respectively. The findings confirm a previous report [7] that constitutive IL-10 production  
in vivo is sustained even in the advanced stages of diverse forms of pre-pubescent malnutrition. By 
contrast,  innate-type  IL-10  production  induced  by  challenge  in  vivo  emerges  as  less  robust  than 
constitutive production of this anti-inflammatory cytokine independently of  the metabolic form of 
acute malnutrition. Moreover, adaptive-type second-tier IL-10 production appears particularly fragile 
in  the  marasmic  form  of  pathology.  Malnutrition-associated  loss  of  the  second-tier  component  of  
anti-inflammatory competence, therefore, may provide an early sign that the ability to sustain regulated 
immune competence is beginning to fail. Perhaps of more fundamental significance, the influence of 
acute malnutrition on second-tier production of IL-10, at least of the adaptive type, appears dependent 
on the metabolic form of malnutrition pathology. This outcome could not be predicted by a model 
centered on chaotic disintegration of immunological capabilities, but is accommodated by the tolerance 
hypothesis  of  malnutrition-associated  inflammatory  decline.  Notably,  these  significant  conclusions 
were possible only pursuant to the studies conducted in vivo, and utilization of the novel technique of 
in vivo cytokine capture permitted a classic in vitro strategy for studying cytokine responses to be 
judged  by  the  outcome  of  an  in  vivo  procedure.  As  a  result,  and  within  the  limits  of  a  focused 
experimental study centered on a single cytokine, this investigation highlights the risk of extrapolating 
in vitro findings to the biological reality of intact organisms.  
The timeframe of the response to LPS in this investigation, both in vivo and in vitro, precludes 
involvement of adaptive immunity, e.g., a thymic-independent humoral response [32]. Consequently, 
this component of the study centers on an innate-type response mediated through TLR-4 signaling [23]. 
The cellular compartment known to both express TLR-4 and produce IL-10 includes dendritic cells, 
mononuclear phagocytes, B cells and activated T cells [33-37], and any combination of these elements 
could  have  contributed  to  the  outcome  reported  herein.  In  relation  to  the  adaptive-type  cytokine 
response, the effector/memory T cell compartment was isolated from its naï ve precursor pool in this Int. J. Environ. Res. Public Health 2011, 8                 
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investigation, and involvement of newly-activated naï ve T cells can be excluded for two independent 
reasons. First, to achieve effector status, naï ve T cells require more than the short response periods 
studied herein [38,39]. Secondly, naï ve T cells cannot differentiate to effector status if stimulated only 
through  the  T  cell  receptor  [40].  However,  in  the  present  investigation,  the  in  vivo  response  was 
elicited by stimulation exclusively through the CD3 molecule and, in vitro, co-stimulation through 
CD28 failed to increase the production of IL-10. The findings reported herein, therefore, separately 
reflect the IL-10-centered regulatory potential of the TLR-4-mediated innate defence compartment and 
of the adaptive effector/memory T cell compartment under challenge by external stimuli.  
The in vivo cytokine capture assay and its interpretation are at the centre of this investigation. No in 
vivo index of cytokine production can be independent of physiological turnover, a potentially crippling 
confounder in relation to blood cytokines because of their brief half-lives that are generally measured 
in minutes [41-44]. The capture assay functions by trapping newly-synthesized cytokine in an antibody 
complex  that  extends  the  half-life  of  the  bound  cytokine  to  hours  or  days  in  the  blood  of  the  
mouse  [42,44-47].  This  assay  strategy  is  simply  an  extension  of  the  physiological  phenomenon 
whereby the clearance of cytokines from the blood is retarded when these molecules form complexes 
with soluble cytokine receptors [48] or anti-cytokine autoantibodies [49]. Therefore, when performed 
with a suitably short assessment period, e.g. four hours as in the present investigation, the capture 
assay is not overwhelmed by turnover and yields an index relating to net systemic cytokine production 
rate in vivo. The in vitro system used herein yields results that may relate more directly to cytokine 
production,  at  least  on  a  per  cell  basis,  than  the  capture  assay.  However,  because  of  the  non-
physiological  context  of  a  cell  culture  microenvironment,  the  findings  stemming  from  in  vitro 
stimulation serve best in a supplementary role.  
The  metabolic  dissimilarities  between  mice  subjected  to  the  low-protein  and  restricted-intake 
protocols, and their respective similarity to the human pathologies of kwashiorkor and marasmus, have 
been noted elsewhere [5,14-18]. Briefly, the low-protein protocol centers on a dietary imbalance, and 
weanling  mice  subjected  to  this  protocol  develop  fatty  liver  and  edema,  the  hallmark  signs  of 
kwashiorkor, after four weeks of wasting disease. When imposed for the periods of time reported in 
this investigation, therefore, the low-protein protocol produces an incipient kwashiorkor. Importantly, 
this protocol permits relative preservation of fat, i.e., relative to the restricted-intake model, as would 
be anticipated in a model relevant to kwashiorkor. In contrast, the restricted-intake protocol induces 
weight  loss  apart  from  dietary  imbalance.  As  expected  in  a  model  of  marasmus,  this  protocol 
stimulates extreme mobilization of fat reserves but fails to produce the hepatic pathology or edema 
seen in mice subjected to the low-protein protocol. Despite their qualitative metabolic differences, 
these forms of experimental malnutrition have consistently failed to exhibit distinct immunological 
characteristics  [1,5,16-18,28,29].  The  findings  of  this  investigation  pertaining  to  innate-type  
second-tier production of IL-10 sustain this pattern, although it is noteworthy that a true decline did not 
occur  in  this  index.  Rather,  its  normal  ontogenetic  rise  was  attenuated.  By  contrast,  a  bona  fide  
early-stage  decline  was  apparent  in  second-tier  IL-10  production  by  the  effector/memory  T  cell 
compartment  in  the  model  of  pre-pubescent  marasmus,  whereas  no  change  in  this  immunological 
index  was  apparent  even  in  the  advanced  stages  of  the  model  of  incipient  kwashiorkor.  The 
significance and basis of this seemingly rare immunological distinction between forms of malnutrition 
pathology deserve research attention.  Int. J. Environ. Res. Public Health 2011, 8                 
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To the extent discernible from the in vitro studies of this investigation, acute weanling malnutrition 
imposes no fundamental influence either on the capacity of mononuclear cells to produce IL-10 in an 
innate-type response to external challenge or on the capacity of effector/memory T cells to produce 
this cytokine in an adaptive-type response. It remains possible that challenge-induced production of 
IL-10 declines in vivo on a per cell basis, e.g., as could be inferred from a report of modestly reduced 
expression  of  LPS  receptor  proteins  by  acutely  protein-deficient  mice  [50].  However,  lymphoid 
involution  out  of  proportion  with  weight  loss  is  a  consistent  feature  of  acute  pre-pubescent 
malnutrition [1,2], and this phenomenon extends to the compartment of cells known to both express 
TLR-4 and produce IL-10. Therefore, loss of LPS-responsive elements appears sufficient to explain 
the inability to sustain a normal ontogenetic rise in innate-type challenge-evoked IL-10 production in 
the two forms of malnutrition pursued in this investigation. An involution-centered interpretation also 
appears sufficient  with respect to  the  outcome  of  adaptive-type IL-10 production in the model of 
marasmus. In fact, within the depleted T cell system that is characteristic of acute malnutrition [1,2], 
loss  of  elements  exhibiting  an  effector/memory  phenotype  is  particularly  profound  in  the  murine 
models used herein [15,51,52]. In this light, the robust systemic effector/memory IL-10 response in the 
model of incipient kwashiorkor is all the more remarkable.  
The  tolerance  model  of  malnutrition-associated  immune  depression  proposes  a  purposeful  
anti-inflammatory  immune  regulation  that  is  sustained,  despite  a  limited  supply  of  energy  and 
substrates, with a view to reducing the risk of autoimmune reactions in catabolic pathologies [1,5,7]. 
This model is the antithesis of the classic paradigm of chaotic immunological disintegration, although 
all aspects of immune competence ultimately must succumb to disintegrative loss if wasting disease is 
permitted to progress indefinitely. In view of the robustness of constitutive IL-10 production in diverse 
forms of weanling malnutrition [7], confirmed herein, a decline in this cytokine response to external 
stimuli may provide an early sign that the ability to regulate immune competence is beginning to fail. 
More fundamentally, the central proposition of the tolerance model is that the primary physiological 
purpose of immune competence in acute pre-pubescent malnutrition is to provide protection against 
challenge  from  self  antigens  rather  than  against  external  challenges.  Therefore,  the  present 
investigation points directly to the tolerance hypothesis with its finding that constitutive production of 
IL-10 is sustained in acute forms of malnutrition while production of this anti-inflammatory cytokine 
generally  declines  in  response  to  external  challenges.  Moreover,  the  tolerance  hypothesis 
accommodates  particularly  well  the  finding  that  the  capacity  to  sustain  second-tier  T  cell  IL-10 
production in acute malnutrition depends on the metabolic form of the pathology and is independent of 
nitrogen  or  energy  decrement.  In  this  context,  it  is  intriguing  that  second-tier  anti-inflammatory 
competence appears to be least fragile in a form of protein and energy deficit  that must create a 
particularly high risk of autoimmune reactions through its emphasis on mobilization of lean tissue with 
its abundance of self antigens. The present investigation, therefore, provides several new findings that 
are accommodated more easily by the tolerance hypothesis than by a model of inflammatory decline 
centered on a physiologically trivial disintegration of inflammatory competence.  
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